Pegasus Farmaco (India) Profile
Key Indicators
- Authorised Capital ₹ 7.65 Cr
as on 04-12-2024
- Paid Up Capital ₹ 4.47 Cr
as on 04-12-2024
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 18.06 Cr
as on 04-12-2024
- Satisfied Charges ₹ 14.79 Cr
as on 04-12-2024
- Revenue -34.27%
(FY 2021)
- Profit -12.97%
(FY 2021)
- Ebitda -2.67%
(FY 2021)
- Net Worth 4.55%
(FY 2021)
- Total Assets -6.56%
(FY 2021)
About Pegasus Farmaco (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 7.65 Cr and a paid-up capital of Rs 4.47 Cr.
The company currently has active open charges totaling ₹18.06 Cr. The company has closed loans amounting to ₹14.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
Raghuveer Beti and Neeraja Beti serve as directors at the Company.
- CIN/LLPIN
U24230TG1995PTC022036
- Company No.
022036
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 1995
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pegasus Farmaco (India) Private Limited offer?
Pegasus Farmaco (India) Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Hand Sanitizers & Personal Hygiene, Organic Soap.
Who are the key members and board of directors at Pegasus Farmaco (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raghuveer Beti  | Managing Director | 12-Apr-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeraja Beti | Director | 30-Sep-2004 | Current |
Financial Performance and Corporate Structure Insights of Pegasus Farmaco (India).
Pegasus Farmaco (India) Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 34.27% decrease. The company also saw a substantial fall in profitability, with a 12.97% decrease in profit. The company's net worth moved up by a moderate rise of 4.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pegasus Farmaco (India)?
In 2021, Pegasus Farmaco (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bethi Medikamente Private LimitedActive 12 years 11 monthsRaghuveer Beti and Neeraja Beti are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Jul 2019 | ₹18.06 Cr | Open |
State Bank Of India Creation Date: 14 May 2007 | ₹12.69 Cr | Satisfied |
Punjab National Bank Creation Date: 26 Oct 2005 | ₹1.90 Cr | Satisfied |
How Many Employees Work at Pegasus Farmaco (India)?
Pegasus Farmaco (India) has a workforce of 127 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pegasus Farmaco (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pegasus Farmaco (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
